Tower Research Capital LLC (Trc) Genfit S.A. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$3.26 - $4.86 $3,484 - $5,195	1,069 New	1,069 $4,000
Q2 2022 Aug 15, 2022	SELL	$3.09 - $4.25 $3,893 - $5,355	-1,260 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$3.14 - $5.04 $3,956 - $6,350	1,260 New	1,260 $5,000
Q4 2021 Feb 14, 2022	SELL	$3.01 - $5.65 $255 - $480	-85 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.58 - $4.14 $716 - $827	-200 Reduced 70.18%	85 $0

Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.63 $1,083 - $1,319	285 New	285 $1,000
Q4 2019 Feb 07, 2020	SELL	$13.55 - $20.14 $867 - $1,288	-64 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$14.92 - $19.94 $3,655 - $4,885	-245 Reduced 79.29%	64 $1,000
Q2 2019 Aug 13, 2019	BUY	$19.74 - $25.65 $6,099 - $7,925	309 New	309 $6,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.